ArticleJournal of experimental & clinical cancer research : CR2025

A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells.

Eunbi Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.